论文信息 - A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer. - 字舞流文

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.

M. Krzakowski | J. Jassem | E. Tan | A. Szczesna | M. Błasińska-Morawiec | P. Zatloukal | N. van Zandwijk | R. Benner | N. Thatcher | J. Au | C. Manegold | P. Serwatowski | S. Meech | A. Ingrosso | N. V. Zandwijk | D. Readett | S. Meech